Key result
Macrophage-targeted PKM2 siRNA nanomaterials cut mortality ~64% and improve cardiac function in septic mice.
Why the study?
Cardiac dysfunction is a major cause of high mortality in sepsis, but the mechanism by which the cardiac microenvironment maintains heart function remains unclear.
Does targeting Rel+ macrophage metabolic reprogramming with PKM2 siRNA-loaded nanomaterials improve cardiac function in sepsis-induced cardiac dysfunction models?
Does targeting Rel+ macrophage metabolic reprogramming with PKM2 siRNA-loaded nanomaterials improve cardiac function in sepsis-induced cardiac dysfunction models?
Targeting Rel+ macrophage metabolic reprogramming via PKM2 inhibition protects against sepsis-induced cardiac dysfunction and improves survival in preclinical models.
Answers are grounded in this paper and cite their sources.
Preclinical targeting of Rel+ macrophages may aid septic cardiac dysfunction; leaves open translation to human trials.
Background Cardiac dysfunction is a major cause of high mortality in sepsis. A well-organized cardiac microenvironment, consisting of cardiomyocytes and non-cardiomyocytes, is essential for maintaining heart function. The mechanism is still unclear. Methods Single-cell and single-nuclei RNA sequencing of the left ventricular tissues from cecal ligation and puncture-induced septic shock mice models were used to detect the change of cardiac cells. Immunofluorescence of myocardial tissue was conducted to validate key cell subpopulations, and PKM2 siRNA-loaded targeting nanomaterials were used to observe the role of Mac2. Results The noncontractile phenotype of cardiomyocytes was major type following sepsis. Rel+ resident macrophages (Rel+ Mac), sepsis-specific cardiac resident macrophages subpopulation, presented metabolic reprogramming with high glycolysis signatures, established a pro-inflammatory niche in septic heart. Mechanistically, Rel+ Mac contributed to cardiomyocyte contractile phenotype switching after sepsis by ITGB1, ITGA9, LAMA2, ITGA4, IL6, TNF, VCAM1 and MMP13 signal axis. Furthermore, Rel+ Mac orchestrated broader microenvironment disruption by interacting with vascular leakage-associated venous endothelial cells and pericytes, vascular hypo-responsiveness associated smooth muscle cells, and cardiac matrix remodeling fibroblasts subpopulation FB3. Targeting Rel+ Mac metabolic reprogramming by PKM2 siRNA-loaded with nanomaterials protected cardiac function after sepsis. Conclusions Rel+ Mac, along with associated microcirculation and stromal cells, disrupt the cardiac niche and synergistically contribute to the occurrence of sepsis-induced cardiac dysfunction. Among which, Rel⁺ macrophages act as key contributors within a broader network (mitochondrial dysfunction, Ca²⁺ mishandling, oxidative stress). These results may provide targets and strategies for the treatment of sepsis-induced myocardial injury in a multifaceted and integrated manner.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied Sepsis-induced cardiac dysfunction. PKM2 siRNA-loaded nanomaterials (PKMsi@NPs) vs. Sepsis control was evaluated on Survival rate (HR 0.3625, 95% CI 0.1300-1.011, p=0.0335). PKM2 siRNA-loaded nanomaterials targeting Rel+ macrophages extended the survival rate from 37.5% to 68.75% (HR 0.3625) and improved cardiac function in septic mice.
Synapse has enriched 10 related papers. Consider them for comparative context: